Zhao, Yonggang
https://orcid.org/0000-0002-2564-3163
Mayo Clinic
I-Mab Biopharma, Gaithersburg, MD, USA
Citations 1
385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results
Harb, Wael A., Adjei, Alex A. , Xing, Yan , Seetharam, Mahesh , Nandagopal, Lakshminarayanan , Xu, Cong , Meng, Yuan, Lee, Linda , Zhao, Yonggang , Wang, Zhengyi, Shen, Joan Huaqiong, Berlin, Jordan D. , Swiecicki, Paul Loren , Gopal, Ajay K. , Meng, Yuan
Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A233.3-A234
